Literature DB >> 35025605

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.

Kjetil Bjornevik1, Marianna Cortese1, Kassandra L Munger1, Alberto Ascherio1,2,3, Brian C Healy4,5,6, Jens Kuhle7, Michael J Mina8,9,10, Yumei Leng8, Stephen J Elledge8, David W Niebuhr11, Ann I Scher11.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr virus (EBV) in a cohort comprising more than 10 million young adults on active duty in the US military, 955 of whom were diagnosed with MS during their period of service. Risk of MS increased 32-fold after infection with EBV but was not increased after infection with other viruses, including the similarly transmitted cytomegalovirus. Serum levels of neurofilament light chain, a biomarker of neuroaxonal degeneration, increased only after EBV seroconversion. These findings cannot be explained by any known risk factor for MS and suggest EBV as the leading cause of MS.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35025605     DOI: 10.1126/science.abj8222

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  144 in total

Review 1.  The immunology of multiple sclerosis.

Authors:  Kathrine E Attfield; Lise Torp Jensen; Max Kaufmann; Manuel A Friese; Lars Fugger
Journal:  Nat Rev Immunol       Date:  2022-05-04       Impact factor: 53.106

2.  Epstein-Barr virus and MS - a causal link.

Authors:  Sarah Lemprière
Journal:  Nat Rev Neurol       Date:  2022-03       Impact factor: 42.937

3.  Epstein-Barr virus sparks brain autoimmunity in multiple sclerosis.

Authors:  Hartmut Wekerle
Journal:  Nature       Date:  2022-03       Impact factor: 49.962

4.  Pandemics disable people - the history lesson that policymakers ignore.

Authors:  Laura Spinney
Journal:  Nature       Date:  2022-02       Impact factor: 49.962

Review 5.  T-cell surveillance of the human brain in health and multiple sclerosis.

Authors:  Joost Smolders; Marvin M van Luijn; Cheng-Chih Hsiao; Jörg Hamann
Journal:  Semin Immunopathol       Date:  2022-04-01       Impact factor: 9.623

6.  The quest to prevent MS - and understand other post-viral diseases.

Authors:  Asher Mullard
Journal:  Nature       Date:  2022-03       Impact factor: 49.962

Review 7.  From the prodromal stage of multiple sclerosis to disease prevention.

Authors:  Ruth Ann Marrie; Mark Allegretta; Lisa F Barcellos; Bruce Bebo; Peter A Calabresi; Jorge Correale; Benjamin Davis; Philip L De Jager; Christiane Gasperi; Carla Greenbaum; Anne Helme; Bernhard Hemmer; Pamela Kanellis; Walter Kostich; Douglas Landsman; Christine Lebrun-Frenay; Naila Makhani; Kassandra L Munger; Darin T Okuda; Daniel Ontaneda; Ronald B Postuma; Jacqueline A Quandt; Sharon Roman; Shiv Saidha; Maria Pia Sormani; Jon Strum; Pamela Valentine; Clare Walton; Kathleen M Zackowski; Yinshan Zhao; Helen Tremlett
Journal:  Nat Rev Neurol       Date:  2022-07-15       Impact factor: 44.711

8.  EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.

Authors:  Sophie Beer; Lucas E Wange; Xiang Zhang; Cornelia Kuklik-Roos; Wolfgang Enard; Wolfgang Hammerschmidt; Antonio Scialdone; Bettina Kempkes
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-20       Impact factor: 12.779

Review 9.  The role of antiviral CD8+ T cells in cognitive impairment.

Authors:  Katie L Reagin; Kristen E Funk
Journal:  Curr Opin Neurobiol       Date:  2022-07-08       Impact factor: 7.070

10.  VirScan: High-throughput Profiling of Antiviral Antibody Epitopes.

Authors:  Ellen L Shrock; Christine L Shrock; Stephen J Elledge
Journal:  Bio Protoc       Date:  2022-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.